Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

The demand for erectile dysfunction devices is largely fueled by the growing incidence of ED, especially among men with chronic health conditions lik ...

The spinout, known as Celea Therapeutics, will advance what’s designed to be an improved version of the drug pirfenidone for ...